Incyte Corp SEC filings INCY

Incyte Corp has 1,003 filings in SEC EDGAR's recent list, going back to Jul 2, 2019. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.

Incyte Corp SEC filings
Form Description Filed Period
SC TO-I/A Filing Jun 13, 2024 —
SC TO-I/A Filing Jun 11, 2024 —
SC TO-I/A Filing Jun 4, 2024 —
SC TO-I/A Filing May 15, 2024 —
SC TO-I Filing May 13, 2024 —
SC TO-C Filing May 13, 2024 —
PX14A6G Filing Apr 24, 2020 —
UPLOAD Letter from the SEC Apr 13, 2020 —
CORRESP Letter to the SEC Apr 7, 2020 —
UPLOAD Letter from the SEC Mar 25, 2020 —
SEC STAFF LETTER Filing Feb 27, 2020 —
SEC STAFF LETTER Filing Feb 6, 2020 —
CT ORDER Filing Nov 7, 2019 —
CT ORDER Filing Nov 7, 2019 —
CT ORDER Filing Nov 7, 2019 —
CT ORDER Filing Nov 7, 2019 —
CT ORDER Filing Nov 7, 2019 —

Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Commercial Physical & Biological Research (SIC 8731)
Listed as
INCY (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Wilmington, DE
SEC filer status
Large accelerated filer
SEC CIK
879169
Former names
INCYTE INC (until Mar 28, 2003); INCYTE GENOMICS INC (until Feb 25, 2003); INCYTE PHARMACEUTICALS INC (until Apr 18, 2000)

Other Services-Commercial Physical & Biological Research companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.